Stone Run Capital, LLC Edwards Lifesciences Corp Transaction History

Stone Run Capital, LLC

$250 Billion
Q2 2024

A detailed history of Stone Run Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stone Run Capital, LLC holds 79,325 shares of EW stock, worth $5.3 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares

79,325

Previous 77,850 1.89%

Holding current value

$5.3 Million

Previous $7.44 Billion 1.51%

% of portfolio

2.93%

Previous 2.84%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $124,342 - $139,107	1,475 Added 1.89%	79,325 $7.33 Billion
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $141,453 - $186,342	-1,950 Reduced 2.44%	77,850 $7.44 Billion
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $283,866 - $357,696	4,600 Added 6.12%	79,800 $6.08 Billion
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $5.21 Million - $7.02 Million	75,200 New	75,200 $5.21 Billion
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $109,280 - $139,904	-1,600 Reduced 2.09%	75,025 $5.6 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $123,555 - $160,935	-1,500 Reduced 1.92%	76,625 $6.33 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.05 Million - $1.55 Million	-12,100 Reduced 13.41%	78,125 $7.43 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $101,960 - $128,340	1,000 Added 1.12%	90,225 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $389,314 - $478,288	-3,660 Reduced 3.94%	89,225 $11.6 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $14,407 - $17,185	-140 Reduced 0.15%	92,885 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $41,920 - $52,380	500 Added 0.54%	93,025 $9.64 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $55,076 - $63,469	-700 Reduced 0.75%	92,525 $7.74 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $40,314 - $52,464	-600 Reduced 0.64%	93,225 $7.44 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $3.49 Million - $4.67 Million	60,650 Added 182.82%	93,825 $6.48 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $217,501 - $336,150	-4,150 Reduced 11.12%	33,175 $6.26 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $102,172 - $116,978	-1,425 Reduced 3.68%	37,325 $8.71 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $12,310 - $15,086	-200 Reduced 0.51%	38,750 $8.52 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $371,280 - $455,520	-8,000 Reduced 17.04%	38,950 $5.97 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $55,785 - $71,175	-1,500 Reduced 3.1%	46,950 $6.55 Million
Q4 2017 Feb 15, 2018	SELL	$33.79 - $39.39 $97,991 - $114,231	-2,900 Reduced 5.65%	48,450 $5.46 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.86 Million - $1.99 Million	51,350	51,350 $5.61 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.

Account

Stone Run Capital, LLC Edwards Lifesciences Corp Transaction History